Justina Burns

Dr. Justina Burns

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2024 in Molecules
Verified
Journal Article
Open access
PDF file
NANaeem Asad
Naeem Asad
MLMichael Lyons
Michael Lyons
SRShirley Muniz Machado Rodrigues
Shirley Muniz Machado Rodrigues
JBJustina Burns
Justina Burns
TRThomas Roper
Thomas Roper
LJLimei Jin
Limei Jin
7-Bromo-4-chloro-1H-indazol-3-amine is a heterocyclic fragment used in the synthesis of Lenacapavir, a potent capsid inhibitor for the treatment of HIV-1 infections. In this manuscript, we describe a new approach to synthesizing 7-bromo-4-chloro-1H-indazol-3-amine from inexpensive 2,6-dichlorobenzonitrile. This synthetic method utilizes a two-step sequence including regioselective bromination and heterocycle formation with hydrazine to give the desired product in an overall isolated yield of 38–45%. The new protocol has been successfully demonstrated on hundred-gram scales without the need for column chromatography purification. This new synthesis provides a potential economical route to the large-scale production of this heterocyclic fragment of Lenacapavir.

8 May 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
ASAnand Shinde
Anand Shinde
RSRamakrishna Sayini
Ramakrishna Sayini
PSPiyal Singh
Piyal Singh
JBJustina Burns
Justina Burns
SASaeed Ahmad
Saeed Ahmad
LJLimei Jin
Limei Jin
Herein, we describe a new five-step approach to prepare 1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine, an important intermediate in the synthesis of lenacapavir. The key step in the sequence is the Weinreb amide-based ketone synthesis, which provides an alternative entry point to the core structural component. Starting from the inexpensive 2-(3,5-difluorophenyl)acetic acid, the Weinreb amide synthesis and the followed nucleophilic substitution afford the ketone in 47% yield. The subsequent functional group manipulation delivers the racemic amine which can be resolved with known mandelic acid resolution. This synthetic route has been demonstrated on decagram scale and affords the racemic amine in an overall isolated yield of 25%.

12 December 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
ASAline Aparecida Nunes de Souza
Aline Aparecida Nunes de Souza
Nagaraju SakkaniNagaraju Sakkani
Nagaraju Sakkani
DGDaryl Guthrie
Daryl Guthrie
RSRajkumar Sahani
Rajkumar Sahani
JSJohn Saathoff
John Saathoff
LJLimei Jin
Limei Jin
(1R,5R)-2,2-Dimethoxybicyclo[3.1.0]hexan-3-one is used in the asymmetric synthesis of lenacapavir. Herein, we report an enantioselective synthesis of this important chiral intermediate from the inexpensive commodity (R)-epichlorohydrin. This synthetic method comprises 6 steps, including a 4-step telescoped bicyclic ketone synthesis, I2-promoted hydroxylation, and an Albright-Goldman oxidation. This sequence affords (1R,5R)-2,2-dimethoxybicyclo[3.1.0]hexan-3-one in an overall 25% isolated yield as an enantiomerically pure compound. The entire process has been successfully demonstrated on a hundred-gram scale.

30 April 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
NANaeem Asad
Naeem Asad
MLMichael Lyons
Michael Lyons
SRShirley Muniz Machado Rodrigues
Shirley Muniz Machado Rodrigues
JBJustina Burns
Justina Burns
TRThomas Roper
Thomas Roper
LJLimei Jin
Limei Jin
7-Bromo-4-chloro-1H-indazol-3-amine is a heterocyclic fragment used in the synthesis of Lenacapavir, a potent capsid inhibitor for the treatment of HIV-1 infections. In this manuscript, we describe a new approach to synthesizing 7-bromo-4-chloro-1H-indazol-3-amine from inexpensive 2,6-dichlorobenzonitrile. This synthetic method utilizes a two-step sequence including a regioselective bromination and heterocycle formation with hydrazine to give the desired product in an overall isolated yield of 38-45%. The new protocol has been successfully demonstrated on hundred-gram scales without the need of column chromatography purifications. This new synthesis provides a potential economical route to large scale production of this heterocyclic fragment of Lenacapavir.

30 April 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
DGDaryl Guthrie
Daryl Guthrie
JSJohn Saathoff
John Saathoff
RSRajkumar Sahani
Rajkumar Sahani
ASAline Aparecida Nunes de Souza
Aline Aparecida Nunes de Souza
DCDaniel Cook
Daniel Cook
LJLimei Jin
Limei Jin
Herein, we describe two practical approaches to synthesize (R)-(+)-1,2-epoxy-5-hexene from inexpensive and readily available raw materials and reagents. The first approach is a two-step sequence, involving an epoxidation with meta-chloroperoxybenzoic acid (mCPBA) and a chiral resolution with (salen)Co(II), producing (R)-(+)-1,2-epoxy-5-hexene in 24-30% of overall yield. The second approach utilizes the readily available (R)-epichlorohydrin as the starting material and features an epoxide ring opening reaction with allylMgCl and the NaOH mediated ring closure reaction. Development of this two-step process affords R-(+)-1,2-epoxy-5-hexene in overall isolated yields of 55-60% with an exceptional purity profile. Both approaches have been successfully demonstrated on 100-200g scales.